Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science

Author:

Inamura KentaroORCID,Hamada TsuyoshiORCID,Bullman Susan,Ugai Tomotaka,Yachida ShinichiORCID,Ogino ShujiORCID

Abstract

Cancer is generally regarded as a localised disease, with the well-established role of the tumour microenvironment. However, the realm of cancer goes beyond the tumour microenvironment, and cancer should also be regarded as a systemic and environmental disease. The exposome (ie,the totality of exposures), which encompasses diets, supplements, smoking, alcohol, other lifestyle factors, medications,etc, likely alters the microbiome (inclusive of bacteria, viruses, archaea, fungi, parasites,etc) and immune system in various body sites and influences tumour phenotypes. The systemic metabolic/inflammatory status, which is likely influenced by exposures and intestinal physiological changes, may affect tissue microenvironment of colorectum and any other organs. Germline genomic factors can modify disease phenotypesviagene-by-environment interactions. Although challenges exist, it is crucial to advance not only basic experimental research that can analyse the effects of exposures, microorganisms and microenvironmental components on tumour evolution but also interdisciplinary human population research that can dissect the complex pathogenic roles of the exposome, microbiome and immunome. Metagenomic, metatranscriptomic and metabolomic analyses should be integrated into well-designed population research combined with advanced methodologies of artificial intelligence and molecular pathological epidemiology. Ideally, a prospective cohort study design that enables biospecimen (such as stool) collection before disease detection should be considered to address reverse causation and recall biases. Robust experimental and observational research together can provide insights into dynamic interactions between environmental exposures, microbiota, tumour and immunity during carcinogenesis processes, thereby helping us develop precision prevention and therapeutic strategies to ultimately reduce the cancer burden.

Funder

Suzuki Foundation for Urological Medicine

Foundation for Promotion of Cancer Research in Japan

National Institutes of Health

National Cancer Center Research and Development Fund

Princess Takamatsu Cancer Research Fund

Mishima Kaiun Memorial Foundation

Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University

Mitsubishi Foundation

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Prevent Cancer Foundation

Takeda Science Foundation

Joint Research Project of the Institute Medical Science, the University of Tokyo

Grant for Lung Cancer Research

Yakult Bio-Science Foundation

AIP Accelerated Program from JST

Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care

Yasuda Memorial Medical Foundation

Cancer Research UK

Publisher

BMJ

Subject

Gastroenterology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3